Daxor Corporation Awarded New Patent for Remote Monitoring of Blood Volume
Oak Ridge, TN, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that Daxor was recently granted a patent for a system to provide remote blood volume monitoring after initial testing with Daxor BVA-100® (Blood Volume Analyzer) diagnostic.
- Oak Ridge, TN, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that Daxor was recently granted a patent for a system to provide remote blood volume monitoring after initial testing with Daxor BVA-100® (Blood Volume Analyzer) diagnostic.
- The recently issued patent provides remote blood volume monitoring through various methods including wearable devices such as smartwatches for a wide variety of medical conditions for which volume assessment is recommended.
- This proprietary technology will help ensure ongoing care is optimized based on the patient’s evolving blood volume status.
- “This patent protects systems and methods for monitoring patients after an initial blood volume measurement.